Related references
Note: Only part of the references are listed.Mechanisms of echinocandin antifungal drug resistance
David S. Perlin
ANTIMICROBIAL THERAPEUTICS REVIEWS (2015)
Innate Inflammatory Response and Immunopharmacologic Activity of Micafungin, Caspofungin, and Voriconazole against Wild-Type and FKS Mutant Candida glabrata Isolates
Nicholas D. Beyda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
The superoxide dismutases of Candida glabrata protect against oxidative damage and are required for lysine biosynthesis, DNA integrity and chronological life survival
Marcela Briones-Martin-del-Campo et al.
MICROBIOLOGY-SGM (2015)
Antimicrobial-Induced DNA Damage and Genomic Instability in Microbial Pathogens
Rebecca S. Shapiro
PLOS PATHOGENS (2015)
Mechanisms of Antifungal Drug Resistance
Leah E. Cowen et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Breakthrough Candidemia Due to Multidrug-Resistant Candida glabrata during Prophylaxis with a Low Dose of Micafungin
Fernando Cesar Bizerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Role of FKS Mutations in Candida glabrata: MIC Values, Echinocandin Resistance, and Multidrug Resistance
Cau D. Pham et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management
David S. Perlin
DRUGS (2014)
Drug-Resistant Candida glabrata Infection in Cancer Patients
Dimitrios Farmakiotis et al.
EMERGING INFECTIOUS DISEASES (2014)
Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2013)
Gain-of-Function Mutations in PDR1, a Regulator of Antifungal Drug Resistance in Candida glabrata, Control Adherence to Host Cells
Luis Vale-Silva et al.
INFECTION AND IMMUNITY (2013)
Expression Plasmids for Use in Candida glabrata
Rebecca E. Zordan et al.
G3-GENES GENOMES GENETICS (2013)
Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations
Maiken Cavling Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
The changing epidemiology of healthcare-associated candidemia over three decades
Daniel Diekema et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
CRS-MIS in Candida glabrata: sphingolipids modulate echinocandin-Fks interaction
Kelley R. Healey et al.
MOLECULAR MICROBIOLOGY (2012)
DNA Mutations Mediate Microevolution between Host-Adapted Forms of the Pathogenic Fungus Cryptococcus neoformans
Denise A. Magditch et al.
PLOS PATHOGENS (2012)
Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata
Selene Ferrari et al.
PLOS ONE (2011)
Epidemiology of Invasive Mycoses in North America
Michael A. Pfaller et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2010)
Candida glabrata Persistence in Mice Does Not Depend on Host Immunosuppression and Is Unaffected by Fungal Amino Acid Auxotrophy
I. D. Jacobsen et al.
INFECTION AND IMMUNITY (2010)
Effect of Candida glabrata FKS1 and FKS2 Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β-D-Glucan Synthase: Implication for the Existing Susceptibility Breakpoint
Guillermo Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A conserved MutS homolog connector domain interface interacts with MutL homologs
Marc L. Mendillo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Role of DNA mismatch repair and double-strand break repair in genome stability and antifungal drug resistance in Candida albicans
Melanie Legrand et al.
EUKARYOTIC CELL (2007)
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Pdr1 regulates multidrug resistance in Candida glabrata:: gene disruption and genome-wide expression studies
John-Paul Vermitsky et al.
MOLECULAR MICROBIOLOGY (2006)
Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants
HF Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Effect of parenteral antibiotic administration on establishment of intestinal colonization by Candida glabrata in adult mice
NJ Pultz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
The role of mutators in the emergence of antibiotic-resistant bacteria
I Chopra et al.
DRUG RESISTANCE UPDATES (2003)
Share Paper
